Corcept Therapeutics Inc
XBER:HTD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Corcept Therapeutics Inc
XBER:HTD
|
US |
|
Rainmaker Systems Inc
OTC:VCTL
|
US |
|
F
|
Foodhub SA
WSE:FHB
|
PL |
Wall Street
Price Targets
HTD Price Targets Summary
Corcept Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
HTD
is 97.95 EUR
with a low forecast of 63.32 EUR and a high forecast of 164.56 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HTD's stock price target?
Price Target
97.95
EUR
According to Wall Street analysts, the average 1-year price target for
HTD
is 97.95 EUR
with a low forecast of 63.32 EUR and a high forecast of 164.56 EUR.
What is Corcept Therapeutics Inc's Revenue forecast?
Projected CAGR
17%
The
compound annual growth rate
of Corcept Therapeutics Inc's revenue for the next 8 years is
17%.
What is Corcept Therapeutics Inc's Operating Income forecast?
Projected CAGR
58%
The
compound annual growth rate
of Corcept Therapeutics Inc's operating income for the next 8 years is
58%.
What is Corcept Therapeutics Inc's Net Income forecast?
Projected CAGR
36%
The
compound annual growth rate
of Corcept Therapeutics Inc's net income for the next 8 years is
36%.
